Skip to content

Use of Personalized Tourniquet Pressure in Knee Arthroscopy.

Evaluation of Knee Arthroscopy under Arterial Occlusion Tourniquet Pressure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4xd6cxm
Enrollment
30
Registered
2026-02-22
Start date
2025-09-07
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Injuries

Interventions

This is a randomized, double-blind, two-arm controlled clinical trial aimed at evaluating the efficacy of personalized Arterial Occlusion Pressure in arthroscopic surgeries. The total number of partic
during the arthroscopy, the tourniquet is set to a personalized pressure derived from this measurement plus a safety margin, lasting for the entire duration of the surgery. In the active control group

Sponsors

Universidade Federal de Juiz de Fora
Lead Sponsor
Universidade Federal de Juiz de Fora
Collaborator

Eligibility

Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Female and male patients, aged between eighteen and forty-five years; with Indication for elective arthroscopic knee procedures (meniscal repair, partial meniscectomy, anterior or posterior cruciate ligament reconstruction); absence of cardiovascular, metabolic, or neurological diseases; clinical eligibility for spinal anesthesia; and ability to provide written informed consent.

Exclusion criteria

Exclusion criteria: Peripheral vascular disease or uncontrolled hypertension; diabetes mellitus, coagulopathies, or autoimmune disorders; previous surgery on the same limb within 12 months; active infection or dermatologic lesion at the cuff site; chronic analgesic or vasoactive medication use; pregnancy; or known neuropathy or intolerance to tourniquet use.

Design outcomes

Primary

MeasureTime frame
to evaluate if the Minimal effective occlusion pressure approach could provide a technically feasible and adequately clear surgical field.

Secondary

MeasureTime frame
to evaluate if the Minimal effective occlusion pressure approach could significantly reduce postoperative pain perception and analgesic consumption

Countries

Brazil

Contacts

Public ContactHeber Cardoso Filho

Universidade Federal de Juiz de Fora

heber.cardoso@estudante.ufjf.br+55-32-984020005

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Jun 28, 2026